Enzyme discovery paves the way for developing universal donor blood

Researchers at DTU and Lund University have discovered enzymes that remove hindrances that stood in the way of developing universal donor blood.

Second round of inflation-related rebates hits 43 drugs from Amgen, Seagen, AbbVie and others

The Department of Health and Human Services on Friday revealed its latest round of coinsurance savings for seniors on drugs with prices rising faster than

June 9, 2023

New two-dose HIV vaccine strategy shows promise for stronger immune response

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade

September 20, 2024

Aclaris’ mixed PhIIb eczema data; Amgen licenses Xeris’ tech; Bolden Tx secures funding

Aclaris Therapeutics reported mixed results for its JAK inhibitor in a Phase IIb eczema study. The biotech seeks a partner for next steps. Aclaris announced

January 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.